Tests a mobile app that tracks voice and symptoms in adults with asthma
Compares a phone-based asthma platform with usual care in adults with asthma.
Plain-language title generated from the registry record
Registry title: ASTHMAXcel Voice Study
Key facts
- Where
- The Bronx, United StatesSee the site
Where in United States
- Montefiore Medical CenterThe Bronx, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Montefiore Medical Center
- Trial code
- NCT06935084
- Record updated
- 8 September 2026
- Original description
The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.Read full original descriptionShow less
Conducting a Randomized Controlled Trial for A Novel Patient-Facing Mobile Platform to Collect and Implement Patient-Reported Outcomes and Voice Biomarkers in Underserved Adult Patients With Asthma
The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.
Inclusion: English speaking; Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication; Able to provide informed consent; Smartphone access (iOS or Android) with data plan.
Exclusion: Severe psychiatric or cognitive problems that would prohibit completion of protocol; Pregnancy.